Onderneming BioPlus Acquisition Corp.
Aandelen
BIOS
KYG112171171
Holdingvennootschappen
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Corporate Officer/Principal | 53 | - | |
Steven Fletcher
PRN | Corporate Officer/Principal | 56 | - |
Alex Serge Vieux
PRN | Corporate Officer/Principal | 66 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01-12-21 |
Jonathan Rigby
CHM | Chairman | 56 | 01-07-21 |
Louis Lange
BRD | Director/Board Member | 72 | 01-12-21 |
Ronald Eastman
BRD | Director/Board Member | 71 | 01-12-21 |
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Shawn Cross
BRD | Director/Board Member | 56 | 01-12-21 |
Glen Giovannetti
BRD | Director/Board Member | 61 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 750 000 | 0 | 0 | 29,61 % |
Aandeel B | 1 | 19 367 477 | 7 437 478 ( 38,40 %) | 0 |
Bedrijfsgegevens
BioPlus Acquisition Corp.
260 Madison Avenue Suite 800
10016, New York
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+103,83% | 4,45 mld. | |
+1,60% | 1,01 mld. | |
+2,19% | 981 mln. | |
+41,91% | 872 mln. | |
+27,88% | 853 mln. | |
+1,68% | 663 mln. | |
+0,54% | 610 mln. | |
-.--% | 600 mln. | |
+26,89% | 560 mln. |